Eyenuk

Eyenuk is a global artificial intelligence (AI) medical technology and services company and a leader in real-world AI eye screening for automatic disease detection and AI Predictive Biomarkers™ for risk assessment and disease monitoring. Eyenuk's first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for the automated detection of diabetic retinopathy. Eyenuk's mission is to screen every eye in the world to ensure the timely diagnosis of sight- and life-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular disease risk, and Alzheimer's disease.